Impact of New Treatments on Hospitalisation, Surgery, Infection, and Mortality in IBD: a Focus Paper by the Epidemiology Committee of ECCO.
about
Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.CT-P13: design, development, and place in therapyExpression of decorin in intestinal tissues of mice with inflammatory bowel disease and its correlation with autophagyInflammatory bowel diseases activity in patients undergoing pelvic radiation therapy.Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future.Anti-inflammatory effects of Dioscorea alata L. anthocyanins in a TNBS-induced colitis model.Management of post-operative Crohn's disease in 2017: where do we go from here?Inflammatory bowel disease versus chronic enteropathy in dogs: are they one and the same?The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.The biologics of ulcerative colitis.Incidence of Bowel Surgery and Associated Risk Factors in Pediatric-Onset Crohn's Disease.Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration.Chest tube drainage versus needle aspiration for primary spontaneous pneumothorax: which is better?Factors Associated With Length of Stay in Veterans With Inflammatory Bowel Disease Hospitalized for an Acute Flare.A review on biosimilar infliximab, CT-P13, in the treatment of inflammatory bowel disease.Impact of Biologic Treatment of Crohn's Disease on the Rate of Surgeries and Other Healthcare Resources: An Analysis of a Nationwide Database From Poland.
P2860
Q31113830-45084BEC-B949-47D6-AB7D-0F15E2FFADD6Q33803728-B205E07A-8125-47B6-90FF-C807ACC79A09Q37582351-ABD5DC71-C1A2-42D5-9751-F5409E8B3DB7Q37677512-0DCBCA90-659A-442D-BD5A-4860A228C131Q38816194-50785208-BCA2-41C9-925B-DCACE9A2A606Q38942174-856DC1FD-ABEA-496F-A64A-D9EDC886CEAAQ38966323-C6E78BDA-9D45-4291-8673-53C4519CFB02Q38982297-C3325BAE-8123-4E38-9C14-C4171363903DQ39018436-FCAEDEDF-D291-40CF-B374-4A185BD1D773Q39037681-5664F342-5E12-4D6F-B4A0-9A4EF2377DA0Q39276665-B8B81C1B-C18B-4135-B3AD-43A4C9CE943DQ41160241-0F050305-00D8-4A2C-8625-EC3AF0BD093DQ41341405-2A2A8AC9-C672-4AB4-A990-07969807AEAAQ47101476-1DFA050E-51A3-4F81-BC07-E0DC581E9010Q47670155-3CDDF668-70ED-4F03-8804-B3FB957D7138Q50073683-78D99112-71FA-4A89-81D6-3FB6D96AFA52Q55363187-B82E830F-AC1B-4309-8BB3-4DDCE9CF451C
P2860
Impact of New Treatments on Hospitalisation, Surgery, Infection, and Mortality in IBD: a Focus Paper by the Epidemiology Committee of ECCO.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Impact of New Treatments on Ho ...... pidemiology Committee of ECCO.
@en
type
label
Impact of New Treatments on Ho ...... pidemiology Committee of ECCO.
@en
prefLabel
Impact of New Treatments on Ho ...... pidemiology Committee of ECCO.
@en
P2093
P356
P1476
Impact of New Treatments on Ho ...... pidemiology Committee of ECCO.
@en
P2093
Corinne Gower-Rousseau
Dana Duricova
Ebbe Langholz
Vito Annese
P304
P356
10.1093/ECCO-JCC/JJV190
P577
2015-10-31T00:00:00Z